60 Degrees Pharmaceuticals, Inc.
SXTP
$1.75
-$0.11-5.91%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 462.60K | 441.30K | 378.20K | 253.60K | 202.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 462.60K | 441.30K | 378.20K | 253.60K | 202.10K |
| Cost of Revenue | 4.89M | 4.17M | 1.37M | 1.17M | 1.29M |
| Gross Profit | -4.42M | -3.73M | -993.60K | -912.80K | -1.08M |
| SG&A Expenses | 5.11M | 5.21M | 4.54M | 4.24M | 2.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.00M | 9.38M | 5.91M | 5.41M | 4.15M |
| Operating Income | -9.53M | -8.94M | -5.54M | -5.15M | -3.95M |
| Income Before Tax | -7.95M | -1.62M | -788.10K | -3.81M | -3.44M |
| Income Tax Expenses | 900.00 | 700.00 | 400.00 | 400.00 | 0.00 |
| Earnings from Continuing Operations | -7.95 | -1.62 | -0.79 | -3.81 | -3.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 38.60K | 47.60K | 53.10K | 48.10K | 8.80K |
| Net Income | -7.91M | -1.57M | -735.20K | -3.77M | -3.43M |
| EBIT | -9.53M | -8.94M | -5.54M | -5.15M | -3.95M |
| EBITDA | -9.49M | -8.89M | -5.49M | -5.10M | -3.90M |
| EPS Basic | -43.69 | 6.50 | -56.54 | -126.10 | -148.47 |
| Normalized Basic EPS | -26.56 | -34.43 | -57.34 | -93.13 | -108.85 |
| EPS Diluted | -43.69 | 6.50 | -56.54 | -126.10 | -148.47 |
| Normalized Diluted EPS | -26.56 | -34.43 | -57.34 | -93.13 | -108.85 |
| Average Basic Shares Outstanding | 957.10K | 558.10K | 394.70K | 264.40K | 207.40K |
| Average Diluted Shares Outstanding | 957.10K | 558.10K | 394.70K | 264.40K | 207.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
